Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 83090-008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 83090-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sintetica Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cartonlabel (Cartonlabel)

Cartonlabel (Cartonlabel)
Not available.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
FDA Label Image

Figure5 (Figure5)

Figure5 (Figure5)
FDA Label Image

Figure6 (Figure6)

Figure6 (Figure6)
FDA Label Image

Stickerlabel (Stickerlabeliv)

Stickerlabel (Stickerlabeliv)
FDA Label Image

Stickerlabel (Stickerlabelsc)

Stickerlabel (Stickerlabelsc)
Bortezomib for Injection is a medication that is mixed with 0.9% Sodium Chloride to create a final concentration of 2.5 mg/mL. It can be administered subcutaneously using either a vial or a syringe. For detailed instructions, please refer to Section 2 of the package insert (421500047-00 C110612:00).*
FDA Label Image

Chemical Structure (Structure)

Chemical Structure (Structure)
FDA Label Image

Viallabel (Viallabel)

Viallabel (Viallabel)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.